Risk of short-term prostate-specific antigen recurrence and failure in patients with prostate cancer
1. For patients with unfavorable nonmetastatic prostate cancer aged above 70 years, PSA levels above 10 ng/mL, and Gleason scores...
Predictors of in-hospital appendiceal perforation in patients with non-perforated acute appendicitis with appendicolithiasis
1. This retrospective study found that in patients initially presenting with acute appendicitis with appendicolithiasis, the length of hospital stay,...
Higher intensity exercise associated with greater decrease in nonalcoholic fatty liver disease risk
1. This analysis of a population-based cohort found that those who engaged in high and moderate decreasing amounts of vigorous...
Long-term risk of arrhythmias increased in patients with inflammatory bowel disease
1. This cohort study found that compared to reference-matched individuals with put inflammatory bowel disease (IBD), any type of IBD...
2 Minute Medicine Rewind October 23, 2023
Noninvasive Bioelectronic Treatment of Postcesarean Pain: A Randomized Trial 1. In this randomized, sham-controlled clinical trial, the use of Transcutaneous...
Live viral vaccines safe for pediatric solid organ transplant recipients
1. This cohort study of pediatric solid organ transplant (SOT) patients found that the measles-mumps-rubella (MMR) and varicella-zoster virus (VZV)...
Fotagliptin monotherapy with alogliptin may be effective for uncontrolled type 2 diabetes
1. Fotagliptin, a novel dipeptidyl peptidase-4 inhibitor (DPP4-i), was found to be noninferior to alogliptin and significantly more effective than...
2 Minute Medicine Rewind October 16, 2023
Health Insurance and Differences in Infant Mortality Rates in the US 1. In this cohort study, patients with Medicaid insurance...
Long-term heat exposure associated with severe maternal morbidity
1. This retrospective cohort of singleton pregnancies found that severe maternal morbidity (SMM) was significantly higher in women who had...
Intravenous dihydroergotamine safe for refractory chronic migraine
1. Intravenous dihydroergotamine (DHE) was found in this retrospective study to be an effective therapeutic option for refractory chronic migraine. ...
